Mirae Asset Global ETFs Holdings’s 10x Genomics TXG Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.78M	Buy	176,954 +50,622	+40%	+$1.33M	0.01%	782
2026 Q1	$2.68M	Buy	126,332 +4,905	+4%	+$98.1K	﹤0.01%	1056
2025 Q4	$1.98M	Buy	121,427 +3,983	+3%	+$60.2K	﹤0.01%	1150
2025 Q3	$1.37M	Sell	117,444 -10,186	-8%	-$133K	﹤0.01%	1312
2025 Q2	$1.48M	Sell	127,630 -21,111	-14%	-$192K	﹤0.01%	1252
2025 Q1	$1.3M	Sell	148,741 -10,424	-7%	-$131K	﹤0.01%	1364
2024 Q4	$2.29M	Buy	159,165 +42,950	+37%	+$678K	﹤0.01%	1063
2024 Q3	$2.62M	Sell	116,215 -25,498	-18%	-$527K	0.01%	988
2024 Q2	$2.76M	Buy	+141,713	New	+$3.71M	0.01%	950

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's TXG Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its 10x Genomics (TXG) stake by 40% in Q2 2026, buying an estimated $1.33M and bringing the position to 176,954 shares worth $6.78M. The position accounts for 0.01% of the portfolio, ranked #782.

Mirae Asset Global ETFs Holdings first reported a position in TXG in Q2 2024 and has held it in 9 quarters since. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

Mirae Asset Global ETFs Holdings held 176,954 shares of 10x Genomics worth $6.78M as of Q2 2026.
Mirae Asset Global ETFs Holdings bought 50,622 10x Genomics shares in Q2 2026, an estimated $1.33M.
10x Genomics made up 0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #782 holding.
Mirae Asset Global ETFs Holdings first reported a position in 10x Genomics in Q2 2024 and has held it in 9 quarters since.
390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.